Encentrio Therapeutics, Inc. — Form D

Encentrio Therapeutics, Inc. of SAN FRANCISCO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2023-04-03. The offering totals $400K, of which $400K was reported sold. Industry: Biotechnology.

Offering

• Filed: 2023-04-03
• Form: D
• Accession: 0001971101-23-000002
• Industry: Biotechnology
• Exemptions: 06b
• Total offering: $400K
• Amount sold: $400K
• Investors: 1
• Date of first sale: 2023-03-20
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-477694

Issuer

• Name: Encentrio Therapeutics, Inc.
• CIK: 0001971101
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Incorporated: 2023
• Address: 1800 OWENS ST., SAN FRANCISCO, CA, 94158
• Phone: 41 79 934 94 49

Officers, directors & promoters (8)

More

• CIK 1971101 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search